This company plays a pivotal role powering video tech devices. Read More

We show you how to find them, and recommend two. Read More

Profit from turnarounds, acquisitions and trends. Read More

Argos Therapeutics (ARGS), a clinical research stage biotech company focusing on the personalized treatment of various cancers based on rallying the individual’s own immune system through its proprietary Arcelis platform, released interim test results this morning on the company’s ongoing Phase 3 ADAPT trial of its AGS-003 compound which met… Read More

Cerus Corp. (CERS), a provider of a leading system for blood infection control, and Rollins Inc. (ROL), a global leader in pest control, may gain ground if the Zika virus creates a health emergency as the summer heats up and the effects of the spring rains and travel patterns increase… Read More

FireEye (NSDQ: FEYE) dipped again on the news that Symantec (SYMC) is set to acquire Blue Coat Systems for $4.65 billion, effectively merging two of FireEye’s largest competitors. Despite the fact that Symantec has been lagging its younger rivals in developing technologies to detect more advanced threats, Blue Coat boasts… Read More

The latest developments and news items regarding our portfolio stocks that you should know about. Read More

It’s summertime, and on Wall Street that usually means low volume days and sluggish price movements.  But Rollins (NYSE: ROL), a pest-control company, has a nifty ten-year record of summer gains.  The stock has rallied 80% of the time during the summer months since 2006.  A move above $29 could… Read More